Protease activated receptor-1 antagonist ameliorates the clinical symptoms of experimental autoimmune encephalomyelitis via inhibiting breakdown of blood-brain barrier
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Protease activated receptor-1 antagonist ameliorates the clinical symptoms of experimental autoimmune encephalomyelitis via inhibiting breakdown of blood-brain barrier
Authors
Keywords
-
Journal
JOURNAL OF NEUROCHEMISTRY
Volume 135, Issue 3, Pages 577-588
Publisher
Wiley
Online
2015-08-19
DOI
10.1111/jnc.13285
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Early detection of thrombin activity in neuroinflammatory disease
- (2013) Dimitrios Davalos et al. ANNALS OF NEUROLOGY
- Extracellular matrix metalloproteinase inducer shows active perivascular cuffs in multiple sclerosis
- (2013) Smriti M. Agrawal et al. BRAIN
- Novel therapeutic options and drug targets in MS
- (2013) Axel Methner et al. Nature Reviews Neurology
- Protein kinase Cβ as a therapeutic target stabilizing blood–brain barrier disruption in experimental autoimmune encephalomyelitis
- (2013) Tobias V. Lanz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Role of SCH79797 in Maintaining Vascular Integrity in Rat Model of Subarachnoid Hemorrhage
- (2013) Junhao Yan et al. STROKE
- Discovery of Octahydroindenes as PAR1 Antagonists
- (2013) Sunkyung Lee et al. ACS Medicinal Chemistry Letters
- Immunologic Privilege in the Central Nervous System and the Blood–Brain Barrier
- (2012) Leslie L Muldoon et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Effects of dimethyl fumarate on neuroprotection and immunomodulation
- (2012) Philipp Albrecht et al. Journal of Neuroinflammation
- Blood-Brain Barrier Alterations in the Cerebral Cortex in Experimental Autoimmune Encephalomyelitis
- (2012) Mariella Errede et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- PAR-1 antagonist SCH79797 ameliorates apoptosis following surgical brain injury through inhibition of ASK1-JNK in rats
- (2012) Anatol Manaenko et al. NEUROBIOLOGY OF DISEASE
- Thrombin receptors and their antagonists: an update on the patent literature
- (2010) Giuseppe Cirino et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Blood–brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAE
- (2010) Jami Bennett et al. JOURNAL OF NEUROIMMUNOLOGY
- Thrombin regulates matrix metalloproteinase-9 expression in human monocytes
- (2009) Chi-Jen Chang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Activation of protease-activated receptor1 mediates induction of matrix metalloproteinase-9 by thrombin in rat primary astrocytes
- (2008) Min Sik Choi et al. BRAIN RESEARCH BULLETIN
- Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets
- (2008) May H. Han et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now